Publication Name	World Journal of Clinical Cases
Manuscript ID	87596
Country	China

Received	2023-08-17 14:36
Peer-Review Started	2023-08-17 14:37
To Make the First Decision
Return for Revision	2023-08-30 07:42
Revised	2023-09-10 01:00
Second Decision	2023-09-28 02:44
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2023-09-28 05:47
Articles in Press	2023-09-28 05:47
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-10-17 13:10
Publish the Manuscript Online	2023-10-25 08:49

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Orthopedics
Manuscript Type	Meta-Analysis
Article Title	Efficacy and safety of different anti-osteoporotic drugs for the spinal fusion surgery: A network meta-analysis
Manuscript Source	Unsolicited Manuscript
All Author List	Xiao-Yuan He, Huan-Xiong Chen and Zhi-Rong Zhao
Funding Agency and Grant Number
Corresponding Author	Zhi-Rong Zhao, PhD, Professor, Spinal Surgery, Hainan Province Clinical Medical Center, No. 31 Longhua Road , Haikou 570100, Hainan Province, China. yinmaosu19930611@163.com
Key Words	Anti-osteoporotic agents; Spinal fusion procedure; Network meta-analysis; Systematic review; Denosumab
Core Tip	This network meta-analysis suggests that teriparatide combined denosumab and teriparatide significantly increased the fusion rate, decreased Oswestry disability index (ODI) without increasing adverse events. Based on current evidence, teriparatide combined denosumab and teriparatide are recommended to increase fusion rate and to reduce ODI in spinal fusion patients. However, the overall quality of evidence is low, the overall certainty of the evidence synthesis is low. In the future, there is a need for more high-quality randomized controlled trials to reassess or confirm this conclusion.
Publish Date	2023-10-25 08:49
Citation	He XY, Chen HX, Zhao ZR. Efficacy and safety of different anti-osteoporotic drugs for the spinal fusion surgery: A network meta-analysis. World J Clin Cases 2023; 11(30): 7350-7362
URL	https://www.wjgnet.com/2307-8960/full/v11/i30/7350.htm
DOI	https://dx.doi.org/10.12998/wjcc.v11.i30.7350

Full Article (PDF)	WJCC-11-7350-with-cover.pdf
Full Article (Word)	WJCC-11-7350.docx
PRISMA 2009 Checklist	87596-PRISMA 2009 Checklist.pdf
Manuscript File	87596_Auto_Edited-LJH-JLW.docx
Answering Reviewers	87596-Answering reviewers.pdf
Audio Core Tip	87596-Audio core tip.mp3
Biostatistics Review Certificate	87596-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	87596-Conflict-of-interest statement.pdf
Copyright License Agreement	87596-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	87596-Language certificate.pdf
Supplementary Material	87596-Supplementary material.pdf
Peer-review Report	87596-Peer-review(s).pdf
Scientific Misconduct Check	87596-Bing-Liu JH-2.png
Scientific Misconduct Check	87596-CrossCheck.png
Scientific Editor Work List	87596-Scientific editor work list.pdf
CrossCheck Report	87596-CrossCheck report.pdf